Sampre Nutritions Ltd

Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has recently formed a Death Cross as its 50-day moving average (DMA) crossed below the 200 DMA, signalling a potential shift towards a bearish trend. This technical development, coupled with deteriorating momentum indicators and a downgrade in its Mojo Grade to Strong Sell, raises concerns about the stock's near-term outlook despite its impressive long-term performance.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Sampre Nutritions Ltd experienced a pronounced decline on 5 Dec 2025, marked by exclusive selling activity and a sharp drop of 4.97% in a single trading session. This downward momentum extends over three consecutive days, signalling distress selling and a lack of buyer interest in the FMCG sector stock.

Sampre Nutritions Ltd experienced a pronounced decline on 4 Dec 2025, with the stock registering a 4.99% fall and exhibiting a rare scenario of exclusive selling interest. The absence of buyers and the presence of only sell orders have intensified concerns about distress selling within this FMCG sector player, marking a continuation of recent downward momentum.

Sampre Nutrition, a microcap player in the FMCG sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of volatile stock returns and contrasting fundamental indicators, prompting investors to reassess the company’s position within the fast-moving consumer goods landscape.

Sampre Nutritions Ltd experienced a pronounced decline on 3 Dec 2025, with the stock registering a sharp fall of 5.00% in a session dominated exclusively by sellers. This stark selling pressure contrasts markedly with the broader market, as the Sensex recorded a comparatively modest dip of 0.36% on the same day, signalling distress selling and a lack of buyer interest in the FMCG stock.

Sampre Nutritions has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an exclusive queue of buy orders dominating the market. This rare scenario, marked by an absence of sellers, signals a potential multi-day circuit phenomenon that has captured investor attention amid a backdrop of strong long-term performance.

Sampre Nutritions Ltd experienced a pronounced decline on 2 Dec 2025, with the stock registering a 4.99% fall in a session dominated exclusively by sellers. This sharp drop comes amid a three-day losing streak, signalling heightened distress selling and a lack of buyer interest in the FMCG sector stock.

Sampre Nutritions Ltd witnessed a sharp decline on 1 Dec 2025, marked by extreme selling pressure and an absence of buyers, resulting in a lower circuit scenario. The stock’s performance today starkly contrasts with the broader market, signalling distress selling and heightened investor caution.

Sampre Nutritions Ltd experienced a pronounced decline on 28 Nov 2025, marked by exclusive selling interest and a lower circuit scenario. The stock recorded a 5.0% drop on the day, contrasting sharply with the Sensex’s modest 0.12% gain, signalling distress selling and a lack of buyer support in the FMCG sector.